Sichuan Huiyu Pharmaceutical Co., Ltd. (SHA:688553)

China flag China · Delayed Price · Currency is CNY
19.51
+0.06 (0.31%)
Apr 29, 2026, 3:00 PM CST
Market Cap8.20B +17.4%
Revenue (ttm)1.03B -5.7%
Net Income22.53M -91.1%
EPS0.05 -91.0%
Shares Out421.46M
PE Ratio363.78
Forward PEn/a
Dividend0.46 (2.33%)
Ex-Dividend DateJun 13, 2025
Volume7,279,513
Average Volume18,988,011
Open19.29
Previous Close19.45
Day's Range19.07 - 19.82
52-Week Range13.48 - 28.28
Beta0.46
RSI50.10
Earnings DateApr 25, 2026

About SHA:688553

Sichuan Huiyu Pharmaceutical Co., Ltd. research and develops, produces, and sells anti-tumor injection in China and internationally. The company offers injection drug products, such as pemetrexed disodium, methrotraxate, docetaxel, azacitidine, oxaliplatin, cyclophosphamide, irinotecan hydrochloride, paclitaxel, bendamustine hydrochloride, decitabine, palonosetron hydrochloride, plerixafor, levetiracetam concentrated solution, amifostine, levofolate calcium, thiotepa, fulvestrant, and milrinone drugs. It also offers moroxydine sodium chloride, ... [Read more]

Sector Healthcare
Founded 2010
Employees 1,331
Stock Exchange Shanghai Stock Exchange
Ticker Symbol 688553
Full Company Profile

Financial Performance

Financial Statements